Health Link

Health Link DNA alternative to Pap smear sparks medical debate DNA alternative to Pap smear sparks medical debate
A high-tech screening tool for cervical cancer is facing pushback from more than a dozen patient groups, who warn that the genetic test could displace a simpler, cheaper and more established mainstay of women's health: the Pap smear.
Health Link Studies find new drugs greatly lower cholesterol Studies find new drugs greatly lower cholesterol
A new class of experimental medicines can dramatically lower cholesterol, raising hopes of a fresh option for people who can't tolerate or don't get enough help from Lipitor and other statin drugs that have been used for this for decades.
Health Link Study finds many preteens have high cholesterol Study finds many preteens have high cholesterol
There's fresh evidence that a lot of young people could be headed for heart trouble. A large study of preteens in Texas found that about one-third of them had borderline or high cholesterol when tested during routine physical exams.
Health Link Autism may be tied to flawed prenatal brain growth Autism may be tied to flawed prenatal brain growth
A small study that examined brains from children who died found abnormal patterns of cell growth in autistic children. The research bolsters evidence that something before birth might cause autism, at least in some cases.
Health Link FDA reviews DNA-based colon cancer screening kits FDA reviews DNA-based colon cancer screening kits
The Food and Drug Administration is weighing the benefits and risks of two experimental colon cancer screening tests which use DNA from a patient's stool to detect dangerous tumors and growths.
Health Link Half of US adults 40 to 75 eligible for statins Half of US adults 40 to 75 eligible for statins
Almost half of Americans ages 40 to 75 and nearly all men over 60 qualify to consider cholesterol-lowering statin drugs under new heart disease prevention guidelines, an analysis concludes.
Health Link IBM's Watson to help sequence cancer DNA IBM's Watson to help sequence cancer DNA
IBM said Wednesday that its Watson cloud computing system will be used in partnership with a New York-based genetic research center mainly to help sequence DNA for the treatment of glioblastoma, the most common type of brain cancer in U.S. adults.